There are 2867 resources available
1416P - Associations between metformin and mortality risks in Asian diabetic patients with prostate cancer undergoing androgen deprivation therapy: A retrospective cohort study
Presenter: Yan Hiu Athena Lee
Session: Poster session 11
803P - Patient-reported outcomes in patients with resected, stage III BRAF V600+ melanoma treated with adjuvant dabrafenib + trametinib: COMBI-APlus study
Presenter: Jean Jacques Grob
Session: Poster session 03
1074P - Peripheral low-density neutrophils identify a subset of NSCLC patients with high PD-L1 tumor expression that can benefit from chemo-immunotherapy
Presenter: Hugo Arasanz
Session: Poster session 15
1417P - Mixed treatment comparisons evaluating contemporary therapies in metastatic castration sensitive prostate cancer (mCSPC): A living systematic review
Presenter: Irbaz Riaz
Session: Poster session 11
804P - Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: 5-year results of the EORTC 1325-MG/Keynote-054 double-blinded phase III trial
Presenter: Alexander Eggermont
Session: Poster session 03
1075P - Tobacco smoking related mutational signatures (MS) in classifying smoking and non-smoking associated metastatic non-small cell lung cancer (mNSCLC)
Presenter: Sophie Ernst
Session: Poster session 15
1418P - Extensive alteration of androgen precursor levels after castration in prostate cancer patients and their association with active androgen level: Importance for treatment intensification
Presenter: Frederic Pouliot
Session: Poster session 11
805P - Predicting recurrence-free survival for patients with stage II melanoma: A validated tool to guide selection for adjuvant systemic therapy
Presenter: Alexander Varey
Session: Poster session 03
1076P - Cancer cachexia associated with gut microbiota and clinical outcomes of patients with non-small cell lung cancer amenable to immunotherapy
Presenter: Taiki Hakozaki
Session: Poster session 15
1419P - Radiobiological parameters for the assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Presenter: Jiaxi Hu
Session: Poster session 11